A quiet analytical research laboratory at night, racks of glass vials along a dim bench.

Licensing and White Label

Two commercial routes exist. White label puts a Vegalab-developed formulation into your brand and packaging, supplied from our GMP manufacture. Licensing grants defined rights to the encapsulation architecture for a category and territory, with technical transfer and ongoing support.

White label

You select a format, we supply finished goods under your brand. Available formats include capsules, sachets and stick packs, oral liquids and shots, professional ampoules, and cosmetic bases where the payload is common with Beauty Science. Each supply agreement includes the specification, certificates of analysis per lot, stability data supporting the stated shelf life, and artwork review against the claim set for your market. Minimum order quantities are format dependent, and first production is preceded by a pilot lot and a stability commitment so your label is defensible before volume commits.

Licensing the platform

A license grants use of the encapsulation architecture in a defined category and territory, usually with exclusivity in one of the two and non-exclusivity in the other. Terms cover field of use, minimum annual volumes, technical transfer scope, quality obligations, and treatment of improvements made by either party. Vegalab retains ownership of the platform intellectual property, which is patent pending, and licensees own their finished-product trademarks and their own clinical or consumer data. Royalty structures are volume-banded rather than flat.

Technical transfer

Where a licensee manufactures, transfer covers process parameters, layer sequencing for the agreed payloads, in-process controls, release specifications and analytical methods including particle size distribution and encapsulation efficiency. We run a qualification batch with the licensee's equipment and personnel, and we do not sign off a transfer until the agreed qualification batches meet specification. Documentation is supplied in a format suited to GMP audit, since a licensee will be inspected on it.

What we need from you

Target market and product classification, the claim set you intend to make, expected annual volumes by format, and the regulatory standing you hold or intend to obtain. Categories we decline are listed on the stewardship page, and reading that first saves a call. We will also say early if the project falls into a declined category, since discovering that after a term sheet has been drafted wastes months on both sides. Expect a technical person on the first call rather than a sales handover.

Key facts

Vegalab manufactures under GMP conditions in Korea, with the multi-layer encapsulation architecture patent pending (Vegalab SA company disclosure)
Shelf life claims must be supported by stability data at the labeled storage condition (ICH Q1A(R2) stability testing)
Technology transfer and process validation are documented elements of the pharmaceutical quality system across the product lifecycle (ICH Q10 pharmaceutical quality system)
Finished product labeling must match the claim rules of the market of sale, which differ between the US, Canada and the EU (21 CFR 101.93; SOR/2003-196; Regulation (EC) 1924/2006)

How our delivery technology applies

What is licensed is layer assignment, not a single recipe. Because each barrier in a route is solved by its own layer, the same platform supports a moisture-sensitive cofactor, a lipophilic polyphenol and a protease-sensitive peptide on one line, with different stacks. That is why a license can cover a category rather than a single stock keeping unit.

Send your category, territory and volume assumptions for a licensing outline.